State Street Corp Vir Biotechnology, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 5,074,731 shares of VIR stock, worth $36.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,074,731

Previous 5,625,533 9.79%

Holding current value

$36.3 Million

Previous $42.1 Million 11.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.74 - $10.17 $3.71 Million - $5.6 Million	-550,802 Reduced 9.79%	5,074,731 $37.2 Million
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $3.85 Million - $5.68 Million	530,645 Added 10.42%	5,625,533 $42.1 Million
Q2 2024 Aug 14, 2024	SELL	$7.63 - $12.66 $15.1 Million - $25 Million	-1,972,733 Reduced 27.91%	5,094,888 $45.3 Million
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $1.34 Million - $1.85 Million	155,539 Added 2.25%	7,067,621 $71.6 Million
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $2.03 Million - $2.69 Million	-261,346 Reduced 3.64%	6,912,082 $69.5 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $16 Million - $43.2 Million	1,754,624 Added 32.38%	7,173,428 $67.2 Million
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $803,671 - $945,352	34,641 Added 0.64%	5,418,804 $133 Million
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $2.05 Million - $2.85 Million	-92,294 Reduced 1.69%	5,384,163 $125 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $7.07 Million - $9.99 Million	-353,960 Reduced 6.07%	5,476,457 $139 Million
Q3 2022 Nov 15, 2022	BUY	$18.26 - $31.1 $5.68 Million - $9.68 Million	311,279 Added 5.64%	5,830,417 $112 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $25.3 Million - $35.4 Million	1,325,374 Added 31.6%	5,519,138 $141 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $35.3 Million - $66.6 Million	1,665,657 Added 65.89%	4,193,764 $108 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $7.44 Million - $13 Million	240,241 Added 10.5%	2,528,107 $106 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $4.74 Million - $7.41 Million	135,931 Added 6.32%	2,287,866 $99.6 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $10.6 Million - $13.9 Million	273,208 Added 14.54%	2,151,935 $102 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $27.8 Million - $87.8 Million	-1,056,977 Reduced 36.0%	1,878,727 $96.3 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $51.2 Million - $87.1 Million	2,006,874 Added 216.06%	2,935,704 $78.6 Million
Q3 2020 Nov 10, 2020	BUY	$28.28 - $53.6 $2.64 Million - $5.01 Million	93,486 Added 11.19%	928,830 $31.9 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $19.8 Million - $33.9 Million	708,966 Added 560.99%	835,344 $34.2 Million
Q1 2020 May 11, 2020	BUY	$12.04 - $60.2 $1.52 Million - $7.61 Million	126,378 New	126,378 $4.33 Million

Others Institutions Holding VIR

# of Institutions

232

Shares Held

90.1M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $948M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Vir Biotechnology, Inc. Transaction History